BoomRx announced the availability of oral semaglutide and tirzepatide options utilizing advanced nanoemulsion delivery for medical clinics, med spas, wellness practices, and telemedicine providers nationwide. The newly introduced formulations apply nanoemulsion technology to convert each dose into microscopic particles, supporting more uniform dispersion and enhanced absorption. This injection-free delivery option offers healthcare providers greater flexibility and consistency as weight-management programs continue to evolve into long-term, scalable care models. “Semaglutide and tirzepatide have become foundational therapies in weight management, and how they’re delivered matters,” says Kurt Lunkwitz, founder and president of BoomRx. “On the clinical side, nanoemulsion delivery provides an injection-free option designed for consistency and predictability—eliminating the performance peaks and troughs that come with using these products. On the distribution side, BoomRx ensures healthcare providers nationwide can quickly and easily fulfill prescriptions for these therapies through one streamlined portal.”